0000855658 Lattice Semiconductor Corp false --12-28 Q2 2024 119,182 125,856 0.01 0.01 10,000,000 10,000,000 0 0 0 0 0.01 0.01 300,000,000 300,000,000 137,765,000 137,765,000 137,340,000 137,340,000 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent 5 0 75 55 0 25 25 75 75 21 May 10, 2024 Esam Elashmawi Interim Chief Executive Officer and Chief Marketing and Strategy Officer True False True False 47,000 May 9, 2025 Includes employee relocation and outplacement costs Includes termination fees on the cancellation of certain contracts 0000855658 2023-12-31 2024-06-29 xbrli:shares 0000855658 2024-07-23 thunderdome:item iso4217:USD 0000855658 2024-03-31 2024-06-29 0000855658 2023-04-02 2023-07-01 0000855658 2023-01-01 2023-07-01 iso4217:USD xbrli:shares 0000855658 2024-06-29 0000855658 2023-12-30 0000855658 2022-12-31 0000855658 2023-07-01 0000855658 us-gaap:CommonStockMember 2023-12-30 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-12-30 0000855658 us-gaap:RetainedEarningsMember 2023-12-30 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-30 0000855658 us-gaap:CommonStockMember 2023-12-31 2024-06-29 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 2024-06-29 0000855658 us-gaap:RetainedEarningsMember 2023-12-31 2024-06-29 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 2024-06-29 0000855658 us-gaap:CommonStockMember 2024-06-29 0000855658 us-gaap:AdditionalPaidInCapitalMember 2024-06-29 0000855658 us-gaap:RetainedEarningsMember 2024-06-29 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-29 0000855658 us-gaap:CommonStockMember 2022-12-31 0000855658 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000855658 us-gaap:RetainedEarningsMember 2022-12-31 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000855658 us-gaap:CommonStockMember 2023-01-01 2023-07-01 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-07-01 0000855658 us-gaap:RetainedEarningsMember 2023-01-01 2023-07-01 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-07-01 0000855658 us-gaap:CommonStockMember 2023-07-01 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 0000855658 us-gaap:RetainedEarningsMember 2023-07-01 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 0000855658 us-gaap:CommonStockMember 2024-03-30 0000855658 us-gaap:AdditionalPaidInCapitalMember 2024-03-30 0000855658 us-gaap:RetainedEarningsMember 2024-03-30 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-30 0000855658 2024-03-30 0000855658 us-gaap:CommonStockMember 2024-03-31 2024-06-29 0000855658 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 2024-06-29 0000855658 us-gaap:RetainedEarningsMember 2024-03-31 2024-06-29 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 2024-06-29 0000855658 us-gaap:CommonStockMember 2023-04-01 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 0000855658 us-gaap:RetainedEarningsMember 2023-04-01 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 0000855658 2023-04-01 0000855658 us-gaap:CommonStockMember 2023-04-02 2023-07-01 0000855658 us-gaap:AdditionalPaidInCapitalMember 2023-04-02 2023-07-01 0000855658 us-gaap:RetainedEarningsMember 2023-04-02 2023-07-01 0000855658 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-02 2023-07-01 xbrli:pure 0000855658 us-gaap:SalesRevenueNetMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:DistributorsMember 2024-03-31 2024-06-29 0000855658 us-gaap:SalesRevenueNetMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:DistributorsMember 2023-04-02 2023-07-01 0000855658 us-gaap:SalesRevenueNetMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:DistributorsMember 2023-12-31 2024-06-29 0000855658 us-gaap:SalesRevenueNetMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:DistributorsMember 2023-01-01 2023-07-01 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember 2023-12-31 2024-06-29 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:LargeDistributorOneMember 2023-12-31 2024-06-29 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:LargeDistributorTwoMember 2023-12-31 2024-06-29 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:ThirdLargestDistributorMember 2023-12-31 2024-06-29 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:LargeDistributorOneMember 2023-01-02 2023-12-30 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:LargeDistributorTwoMember 2023-01-02 2023-12-30 0000855658 us-gaap:AccountsReceivableMember lscc:SellThroughDistributorsConcentrationRiskMember lscc:ThirdLargestDistributorMember 2023-01-02 2023-12-30 0000855658 us-gaap:SalesChannelThroughIntermediaryMember us-gaap:ProductMember 2024-03-31 2024-06-29 0000855658 us-gaap:SalesChannelThroughIntermediaryMember us-gaap:ProductMember 2023-04-02 2023-07-01 0000855658 us-gaap:SalesChannelThroughIntermediaryMember us-gaap:ProductMember 2023-12-31 2024-06-29 0000855658 us-gaap:SalesChannelThroughIntermediaryMember us-gaap:ProductMember 2023-01-01 2023-07-01 0000855658 us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:ProductMember 2024-03-31 2024-06-29 0000855658 us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:ProductMember 2023-04-02 2023-07-01 0000855658 us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:ProductMember 2023-12-31 2024-06-29 0000855658 us-gaap:SalesChannelDirectlyToConsumerMember us-gaap:ProductMember 2023-01-01 2023-07-01 0000855658 country:CN 2024-03-31 2024-06-29 0000855658 country:CN 2023-04-02 2023-07-01 0000855658 country:CN 2023-12-31 2024-06-29 0000855658 country:CN 2023-01-01 2023-07-01 0000855658 country:JP 2024-03-31 2024-06-29 0000855658 country:JP 2023-04-02 2023-07-01 0000855658 country:JP 2023-12-31 2024-06-29 0000855658 country:JP 2023-01-01 2023-07-01 0000855658 lscc:OtherAsiaMember 2024-03-31 2024-06-29 0000855658 lscc:OtherAsiaMember 2023-04-02 2023-07-01 0000855658 lscc:OtherAsiaMember 2023-12-31 2024-06-29 0000855658 lscc:OtherAsiaMember 2023-01-01 2023-07-01 0000855658 srt:AsiaMember 2024-03-31 2024-06-29 0000855658 srt:AsiaMember 2023-04-02 2023-07-01 0000855658 srt:AsiaMember 2023-12-31 2024-06-29 0000855658 srt:AsiaMember 2023-01-01 2023-07-01 0000855658 srt:AmericasMember 2024-03-31 2024-06-29 0000855658 srt:AmericasMember 2023-04-02 2023-07-01 0000855658 srt:AmericasMember 2023-12-31 2024-06-29 0000855658 srt:AmericasMember 2023-01-01 2023-07-01 0000855658 srt:EuropeMember 2024-03-31 2024-06-29 0000855658 srt:EuropeMember 2023-04-02 2023-07-01 0000855658 srt:EuropeMember 2023-12-31 2024-06-29 0000855658 srt:EuropeMember 2023-01-01 2023-07-01 0000855658 country:US 2024-06-29 0000855658 country:US 2023-12-30 0000855658 country:TW 2024-06-29 0000855658 country:TW 2023-12-30 0000855658 country:PH 2024-06-29 0000855658 country:PH 2023-12-30 0000855658 country:CN 2024-06-29 0000855658 country:CN 2023-12-30 0000855658 lscc:OtherMember 2024-06-29 0000855658 lscc:OtherMember 2023-12-30 0000855658 lscc:ForeignCountriesMember 2024-06-29 0000855658 lscc:ForeignCountriesMember 2023-12-30 utr:Y 0000855658 us-gaap:RevolvingCreditFacilityMember lscc:The2022CreditAgreementMember 2022-09-01 2022-09-01 0000855658 us-gaap:RevolvingCreditFacilityMember lscc:The2022CreditAgreementMember 2022-09-01 0000855658 us-gaap:RevolvingCreditFacilityMember lscc:The2022CreditAgreementMember 2024-06-29 0000855658 us-gaap:RevolvingCreditFacilityMember lscc:The2022CreditAgreementMember 2023-12-30 0000855658 us-gaap:RevolvingCreditFacilityMember lscc:The2022CreditAgreementMember 2023-12-31 2024-06-29 0000855658 lscc:Q32023PlanMember 2024-03-31 2024-06-29 0000855658 lscc:Q32023PlanMember 2023-12-31 2024-06-29 0000855658 lscc:Q32023PlanMember 2024-06-29 0000855658 us-gaap:EmployeeSeveranceMember 2023-12-30 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2023-12-30 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2023-12-30 0000855658 us-gaap:OtherRestructuringMember 2023-12-30 0000855658 us-gaap:EmployeeSeveranceMember 2023-12-31 2024-06-29 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2023-12-31 2024-06-29 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2023-12-31 2024-06-29 0000855658 us-gaap:OtherRestructuringMember 2023-12-31 2024-06-29 0000855658 us-gaap:EmployeeSeveranceMember 2024-06-29 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2024-06-29 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2024-06-29 0000855658 us-gaap:OtherRestructuringMember 2024-06-29 0000855658 us-gaap:EmployeeSeveranceMember 2022-12-31 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2022-12-31 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2022-12-31 0000855658 us-gaap:OtherRestructuringMember 2022-12-31 0000855658 us-gaap:EmployeeSeveranceMember 2023-01-01 2023-07-01 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2023-01-01 2023-07-01 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2023-01-01 2023-07-01 0000855658 us-gaap:OtherRestructuringMember 2023-01-01 2023-07-01 0000855658 us-gaap:EmployeeSeveranceMember 2023-07-01 0000855658 lscc:LeaseTerminationAndFixedAssetsMember 2023-07-01 0000855658 lscc:SoftwareContractsAndEngineeringToolsMember 2023-07-01 0000855658 us-gaap:OtherRestructuringMember 2023-07-01 0000855658 us-gaap:ResearchAndDevelopmentExpenseMember 2024-03-31 2024-06-29 0000855658 us-gaap:ResearchAndDevelopmentExpenseMember 2023-04-02 2023-07-01 0000855658 us-gaap:ResearchAndDevelopmentExpenseMember 2023-12-31 2024-06-29 0000855658 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-07-01 0000855658 lscc:AmortizationOfAcquiredIntangibleAssetsMember 2024-03-31 2024-06-29 0000855658 lscc:AmortizationOfAcquiredIntangibleAssetsMember 2023-04-02 2023-07-01 0000855658 lscc:AmortizationOfAcquiredIntangibleAssetsMember 2023-12-31 2024-06-29 0000855658 lscc:AmortizationOfAcquiredIntangibleAssetsMember 2023-01-01 2023-07-01 0000855658 us-gaap:CostOfSalesMember 2024-03-31 2024-06-29 0000855658 us-gaap:CostOfSalesMember 2023-04-02 2023-07-01 0000855658 us-gaap:CostOfSalesMember 2023-12-31 2024-06-29 0000855658 us-gaap:CostOfSalesMember 2023-01-01 2023-07-01 0000855658 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2024-03-31 2024-06-29 0000855658 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-04-02 2023-07-01 0000855658 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-12-31 2024-06-29 0000855658 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-07-01 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember srt:ExecutiveOfficerMember lscc:TsrRelativeToPhlxSemiconductorSectorIndex75thPercentileMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember srt:ExecutiveOfficerMember lscc:TsrRelativeToPhlxSemiconductorSectorIndex75thPercentileMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2024-03-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:ExecutiveOfficerMember 2023-12-31 2024-06-29 0000855658 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 2024-06-29 0000855658 lscc:PerformanceSharesGrantedIn2018Member srt:MinimumMember srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2023-12-31 2024-06-29 0000855658 lscc:PerformanceSharesGrantedIn2018Member srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2023-12-31 2024-06-29 0000855658 lscc:PerformanceSharesGrantedIn2018Member srt:ExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2023-12-31 2024-06-29 0000855658 lscc:AwardsWithMarketConditionOrPerformanceConditionMember 2024-03-31 2024-06-29 0000855658 lscc:AwardsWithMarketConditionOrPerformanceConditionMember 2023-12-31 2024-06-29 0000855658 lscc:AwardsWithMarketConditionOrPerformanceConditionMember 2023-04-02 2023-07-01 0000855658 lscc:AwardsWithMarketConditionOrPerformanceConditionMember 2023-01-01 2023-07-01 0000855658 us-gaap:PerformanceSharesMember 2023-12-30 0000855658 us-gaap:PerformanceSharesMember 2023-12-31 2024-06-29 0000855658 us-gaap:PerformanceSharesMember 2024-06-29 0000855658 lscc:RepurchaseProgram2024Member 2023-11-30 0000855658 lscc:RepurchaseProgram2024Member 2024-03-31 2024-06-29 0000855658 lscc:RepurchaseProgram2024Member 2023-12-31 2024-06-29 0000855658 lscc:RepurchaseProgram2024Member 2024-06-29 0000855658 us-gaap:DomesticCountryMember 2024-03-31 2024-06-29 0000855658 us-gaap:DomesticCountryMember 2023-12-31 2024-06-29 0000855658 us-gaap:OtherNoncurrentLiabilitiesMember 2024-06-29 0000855658 us-gaap:OtherNoncurrentLiabilitiesMember 2023-12-30 0000855658 lscc:ActionInOregonInConnectionWithSaleOfCertainProductsMember 2024-05-24 2024-05-24

Table of Contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED June 29, 2024

OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM __________ TO __________

Commission file number 000-18032

LATTICE SEMICONDUCTOR CORPORATION

(Exact name of Registrant as specified in its charter)

State of Delaware | 93-0835214
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.)
5555 NE Moore Court, Hillsboro, OR | 97124
(Address of principal executive offices) | (Zip Code)

(503) 268-8000

(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class | Trading Symbol | Name of each exchange on which registered
Common Stock, $.01 par value | LSCC | Nasdaq Global Select Market

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☒ | Accelerated filer ☐
Non-accelerated filer ☐ | Smaller reporting company ☐
| Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Number of shares of common stock outstanding as of July 23, 2024 | 137,772,234

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

| Note Regarding Forward-Looking Statements | 3
PART I. | FINANCIAL INFORMATION | Page
Item 1. | Financial Statements | 4
| Consolidated Statements of Operations – Three and Six Months Ended June 29, 2024 and July 1, 2023 (unaudited) | 4
| Consolidated Statements of Comprehensive Income – Three and Six Months Ended June 29, 2024 and July 1, 2023 (unaudited) | 5
| Consolidated Balance Sheets – June 29, 2024 and December 30, 2023 (unaudited) | 6
| Consolidated Statements of Cash Flows – Six Months Ended June 29, 2024 and July 1, 2023 (unaudited) | 7
| Consolidated Statements of Stockholders' Equity – Three and Six Months Ended June 29, 2024 and July 1, 2023 (unaudited) | 8
| Notes to Consolidated Financial Statements (unaudited) | 10
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 18
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 25
Item 4. | Controls and Procedures | 25
PART II. | OTHER INFORMATION |
Item 1. | Legal Proceedings | 26
Item 1A. | Risk Factors | 26
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 27
Item 5. | Other Information | 27
Item 6. | Exhibits | 28
| Signatures | 29

- 2 -

Table of Contents

Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements that involve estimates, assumptions, risks, and uncertainties. Any statements about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and may be forward-looking. We use words or phrases such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “plan,” "possible," “predict,” “projects,” “may,” “will,” “should,” “continue,” “ongoing,” “future,” “potential,” and similar words or phrases to identify forward-looking statements.

Forward-looking statements include, but are not limited to, statements about: our target or expected financial performance and our ability to achieve those results; our expectations related to attracting and retaining key personnel; future impacts of the ongoing military conflicts between Ukraine and Russia, and in the Middle East, and the outbreak of new, or expansion of current, military conflicts or terrorism; the impact of any continuing trade or travel restrictions on the export and import of products between the U.S. and China; the impact of any deterioration in relations between Taiwan and China, and other factors affecting military, political, or economic conditions in Taiwan or elsewhere in Asia; the impact of tariffs, trade sanctions, license requirements or similar actions on our suppliers and customers; the impact of inflationary pressures; future impacts of global pandemics, epidemics, and other public health problems; our business strategy; our opportunities to increase our addressable market; our expectations and strategies regarding market trends and opportunities, including market drivers such as wireless and wireline communications infrastructure deployments, data center servers and networking equipment, client computing platforms, industrial Internet of Things, factory automation, robotics, automotive electronics, smart homes, prosumers, and other applications; our expectations regarding the growth of AI-related revenue; our expectations regarding our customer base and the impacts of our customers’ actions on our business; our expectations regarding both new and existing product offerings; our gross margin growth and our strategies to achieve gross margin growth and other financial results; our future investments in research and development; future financial results or accounting treatments; our judgments involved in accounting matters, including revenue recognition, inventories and cost of revenue, and income taxes; actions we may take regarding the design and continued effectiveness of our internal controls over financial reporting; our use of cash; our beliefs regarding the adequacy of our liquidity, capital resources and facilities; whether we will consider and act upon acquisition opportunities to extend our product, technology and product offerings, and the impact of such opportunities on our business; our expectations regarding taxes, including unrecognized tax benefits, and tax adjustments and allowances; whether we will pursue future stock repurchases and how any future repurchases will be funded; the future price volatility of our stock and the effects of that volatility; our ability to prevent and respond to information technology system failures, security breaches and incidents, cyber-attacks or fraud, and the occurrence and impact of such cybersecurity incidents; the costs of mitigating cybersecurity risks; the impact of artificial intelligence ("AI"); the impact of laws and regulations addressing privacy, data protection, and cybersecurity and our ability to comply with the same; our ability to comply with other laws and regulations, the costs of such compliance, and costs incurred if we fail to comply with such laws and regulations; and our beliefs regarding legal or administrative proceedings.

These forward-looking statements are based on estimates and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those statements expressed in the forward-looking statements. The key factors, among others, that could cause our actual results to differ materially from the forward-looking statements include global economic conditions and uncertainty, including as a result of trade-related restrictions or tariffs, inflationary pressures, or the effect of any downturn in the economy on capital markets and credit markets; the effects of global military conflicts, pandemics or widespread global health problems and the actions by governments, businesses, and individuals in response to the situation, the effects of which may give rise to or amplify the risks associated with many of these factors listed here; our ability to attract and retain key personnel; and other factors more fully described herein or that are otherwise described from time to time in our filings with the Securities and Exchange Commission ("SEC"), including, but not limited to, the items discussed in Part I, Item 1A, “Risk Factors,” in our Annual Report on Form 10-K for the fiscal year ended December 30, 2023 filed with the SEC on February 16, 2024 and any additional or updated risk factors discussed in any subsequent Quarterly Report on Form 10-Q filed since that date.

You should not unduly rely on forward-looking statements because our actual results could differ materially from those expressed by us. In addition, any forward-looking statement applies only as of the date of this filing. We do not plan to, and undertake no obligation to, update any forward-looking statements to reflect new information or new events, circumstances or developments, or otherwise.

- 3 -

Table of Contents

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands, except per share data) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Revenue |  | $ | 124,076 |  |  | $ | 190,079 |  |  | $ | 264,891 |  |  | $ | 374,389 |
Cost of revenue |  |  | 39,325 |  |  |  | 57,518 |  |  |  | 83,932 |  |  |  | 113,227 |
Gross margin |  |  | 84,751 |  |  |  | 132,561 |  |  |  | 180,959 |  |  |  | 261,162 |
Operating expenses: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Research and development |  |  | 38,733 |  |  |  | 41,946 |  |  |  | 79,324 |  |  |  | 77,935 |
Selling, general, and administrative |  |  | 20,005 |  |  |  | 36,788 |  |  |  | 56,474 |  |  |  | 69,366 |
Amortization of acquired intangible assets |  |  | 869 |  |  |  | 869 |  |  |  | 1,739 |  |  |  | 1,739 |
Restructuring |  |  | 2,579 |  |  |  | (112 | ) |  |  | 4,283 |  |  |  | (82 | )
Total operating expenses |  |  | 62,186 |  |  |  | 79,491 |  |  |  | 141,820 |  |  |  | 148,958 |
Income from operations |  |  | 22,565 |  |  |  | 53,070 |  |  |  | 39,139 |  |  |  | 112,204 |
Interest income (expense), net |  |  | 933 |  |  |  | 189 |  |  |  | 2,240 |  |  |  | (366 | )
Other income (expense), net |  |  | 254 |  |  |  | (176 | ) |  |  | 208 |  |  |  | (271 | )
Income before income taxes |  |  | 23,752 |  |  |  | 53,083 |  |  |  | 41,587 |  |  |  | 111,567 |
Income tax expense |  |  | 1,121 |  |  |  | 2,439 |  |  |  | 4,160 |  |  |  | 5,000 |
Net income |  | $ | 22,631 |  |  | $ | 50,644 |  |  | $ | 37,427 |  |  | $ | 106,567 |
Net income per share: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  | $ | 0.16 |  |  | $ | 0.37 |  |  | $ | 0.27 |  |  | $ | 0.77 |
Diluted |  | $ | 0.16 |  |  | $ | 0.36 |  |  | $ | 0.27 |  |  | $ | 0.76 |
Shares used in per share calculations: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Basic |  |  | 137,548 |  |  |  | 137,735 |  |  |  | 137,480 |  |  |  | 137,573 |
Diluted |  |  | 138,243 |  |  |  | 139,768 |  |  |  | 138,485 |  |  |  | 139,966 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 4 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(unaudited)

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Net income |  | $ | 22,631 |  |  | $ | 50,644 |  |  | $ | 37,427 |  |  | $ | 106,567 |
Other comprehensive income (loss): |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Translation adjustment |  |  | (296 | ) |  |  | (457 | ) |  |  | (770 | ) |  |  | (268 | )
Comprehensive income |  | $ | 22,335 |  |  | $ | 50,187 |  |  | $ | 36,657 |  |  | $ | 106,299 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 5 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED BALANCE SHEETS

(unaudited)

|  | June 29, |  |  | December 30, |
(In thousands, except share and par value data) |  | 2024 |  |  | 2023 |
ASSETS |  |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 109,216 |  |  | $ | 128,317 |
Accounts receivable, net of allowance for credit losses |  |  | 103,442 |  |  |  | 104,373 |
Inventories, net |  |  | 101,556 |  |  |  | 98,826 |
Prepaid expenses and other current assets |  |  | 38,990 |  |  |  | 36,430 |
Total current assets |  |  | 353,204 |  |  |  | 367,946 |
Property and equipment, less accumulated depreciation of $119,182 at June 29, 2024 and $125,856 at December 30, 2023 |  |  | 50,801 |  |  |  | 49,546 |
Operating lease right-of-use assets |  |  | 17,326 |  |  |  | 14,487 |
Intangible assets, net |  |  | 19,016 |  |  |  | 20,974 |
Goodwill |  |  | 315,358 |  |  |  | 315,358 |
Deferred income taxes |  |  | 57,329 |  |  |  | 57,762 |
Other long-term assets |  |  | 14,486 |  |  |  | 14,821 |
Total assets |  | $ | 827,520 |  |  | $ | 840,894 |
LIABILITIES AND STOCKHOLDERS' EQUITY |  |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |  |
Accounts payable |  | $ | 34,957 |  |  | $ | 34,487 |
Accrued liabilities |  |  | 32,088 |  |  |  | 36,048 |
Accrued payroll obligations |  |  | 13,239 |  |  |  | 26,865 |
Total current liabilities |  |  | 80,284 |  |  |  | 97,400 |
Long-term operating lease liabilities, net of current portion |  |  | 11,975 |  |  |  | 10,739 |
Other long-term liabilities |  |  | 36,412 |  |  |  | 40,735 |
Total liabilities |  |  | 128,671 |  |  |  | 148,874 |
Contingencies (Note 12) |  |  |  |  |  |  |  |
Stockholders' equity: |  |  |  |  |  |  |  |
Preferred stock, $.01 par value, 10,000,000 shares authorized, none issued and outstanding |  |  | — |  |  |  | — |
Common stock, $.01 par value, 300,000,000 shares authorized; 137,765,000 shares issued and outstanding as of June 29, 2024 and 137,340,000 shares issued and outstanding as of December 30, 2023 |  |  | 1,378 |  |  |  | 1,373 |
Additional paid-in capital |  |  | 515,753 |  |  |  | 545,586 |
Retained earnings |  |  | 185,394 |  |  |  | 147,967 |
Accumulated other comprehensive loss |  |  | (3,676 | ) |  |  | (2,906 | )
Total stockholders' equity |  |  | 698,849 |  |  |  | 692,020 |
Total liabilities and stockholders' equity |  | $ | 827,520 |  |  | $ | 840,894 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 6 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

|  | Six Months Ended |
|  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |
Cash flows from operating activities: |  |  |  |  |  |  |  |
Net income |  | $ | 37,427 |  |  | $ | 106,567 |
Adjustments to reconcile net income to net cash provided by (used in) operating activities: |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 18,385 |  |  |  | 16,578 |
Stock-based compensation expense |  |  | 21,713 |  |  |  | 35,744 |
Change in deferred income tax provision |  |  | (969 | ) |  |  | (882 | )
Amortization of right-of-use assets |  |  | 3,812 |  |  |  | 3,317 |
Impairment of operating lease right-of-use asset |  |  | 384 |  |  |  | — |
Other non-cash adjustments |  |  | 133 |  |  |  | 110 |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Accounts receivable, net |  |  | 931 |  |  |  | (2,569 | )
Inventories, net |  |  | (2,730 | ) |  |  | (1,115 | )
Prepaid expenses and other assets |  |  | (6,717 | ) |  |  | (3,657 | )
Accounts payable |  |  | 470 |  |  |  | (772 | )
Accrued liabilities |  |  | (3,523 | ) |  |  | (15,078 | )
Accrued payroll obligations |  |  | (13,626 | ) |  |  | (19,045 | )
Operating lease liabilities, current and long-term portions |  |  | (4,248 | ) |  |  | (3,740 | )
Net cash provided by (used in) operating activities |  |  | 51,442 |  |  |  | 115,458 |
Cash flows from investing activities: |  |  |  |  |  |  |  |
Capital expenditures |  |  | (10,581 | ) |  |  | (11,943 | )
Cash paid for software and intellectual property licenses |  |  | (7,607 | ) |  |  | (5,799 | )
Net cash provided by (used in) investing activities |  |  | (18,188 | ) |  |  | (17,742 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |
Restricted stock unit tax withholdings |  |  | (26,980 | ) |  |  | (39,189 | )
Proceeds from issuance of common stock |  |  | 5,246 |  |  |  | 4,750 |
Repurchase of common stock |  |  | (29,999 | ) |  |  | (20,006 | )
Repayment of long-term debt |  |  | — |  |  |  | (85,000 | )
Net cash provided by (used in) financing activities |  |  | (51,733 | ) |  |  | (139,445 | )
Effect of exchange rate change on cash |  |  | (622 | ) |  |  | (220 | )
Net increase (decrease) in cash and cash equivalents |  |  | (19,101 | ) |  |  | (41,949 | )
Beginning cash and cash equivalents |  |  | 128,317 |  |  |  | 145,722 |
Ending cash and cash equivalents |  | $ | 109,216 |  |  | $ | 103,773 |
Supplemental disclosure of cash flow information and non-cash investing and financing activities: |  |  |  |  |  |  |  |
Interest paid |  | $ | — |  |  | $ | 2,962 |
Income taxes paid, net of refunds |  | $ | 3,886 |  |  | $ | 6,837 |
Operating lease payments |  | $ | 4,564 |  |  | $ | 4,082 |
Accrued purchases of plant and equipment |  | $ | 160 |  |  | $ | 571 |
Operating lease right-of-use assets obtained in exchange for lease obligations |  | $ | 7,162 |  |  | $ | 393 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 7 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(unaudited)

The following summarizes the changes in total equity for the six-month period ended June 29, 2024:

|  | Common Stock ($.01 par value) |  |  | Additional Paid-in |  |  | Retained |  |  | Accumulated Other Comprehensive |  |  |  |  |
(In thousands, except par value data) |  | Shares |  |  | Amount |  |  | Capital |  |  | Earnings |  |  | Loss |  |  | Total |
Balances, December 30, 2023 |  |  | 137,340 |  |  | $ | 1,373 |  |  | $ | 545,586 |  |  | $ | 147,967 |  |  | $ | (2,906 | ) |  | $ | 692,020 |
Components of comprehensive income, net of tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the six months ended June 29, 2024 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 37,427 |  |  |  | — |  |  |  | 37,427 |
Other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (770 | ) |  |  | (770 | )
Total comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 36,657 |
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes |  |  | 833 |  |  |  | 9 |  |  |  | (21,743 | ) |  |  | — |  |  |  | — |  |  |  | (21,734 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 21,713 |  |  |  | — |  |  |  | — |  |  |  | 21,713 |
Repurchase of common stock |  |  | (408 | ) |  |  | (4 | ) |  |  | (29,803 | ) |  |  | — |  |  |  | — |  |  |  | (29,807 | )
Balances, June 29, 2024 |  |  | 137,765 |  |  | $ | 1,378 |  |  | $ | 515,753 |  |  | $ | 185,394 |  |  | $ | (3,676 | ) |  | $ | 698,849 |

The following summarizes the changes in total equity for the six-month period ended July 1, 2023:

|  | Common Stock ($.01 par value) |  |  | Additional Paid-in |  |  | Accumulated |  |  | Accumulated Other Comprehensive |  |  |  |  |
(In thousands, except par value data) |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Loss |  |  | Total |
Balances, December 31, 2022 |  |  | 137,099 |  |  | $ | 1,371 |  |  | $ | 599,300 |  |  | $ | (111,094 | ) |  | $ | (2,414 | ) |  | $ | 487,163 |
Components of comprehensive income, net of tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the six months ended July 1, 2023 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 106,567 |  |  |  | — |  |  |  | 106,567 |
Other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (268 | ) |  |  | (268 | )
Total comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 106,299 |
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes |  |  | 965 |  |  |  | 9 |  |  |  | (34,448 | ) |  |  | — |  |  |  | — |  |  |  | (34,439 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 35,744 |  |  |  | — |  |  |  | — |  |  |  | 35,744 |
Repurchase of common stock |  |  | (241 | ) |  |  | (2 | ) |  |  | (20,004 | ) |  |  | — |  |  |  | — |  |  |  | (20,006 | )
Balances, July 1, 2023 |  |  | 137,823 |  |  | $ | 1,378 |  |  | $ | 580,592 |  |  | $ | (4,527 | ) |  | $ | (2,682 | ) |  | $ | 574,761 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 8 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (continued)

(unaudited)

The following summarizes the changes in total equity for the three-month period ended June 29, 2024:

|  | Common Stock ($.01 par value) |  |  | Additional Paid-in |  |  | Retained |  |  | Accumulated Other Comprehensive |  |  |  |  |
(In thousands, except par value data) |  | Shares |  |  | Amount |  |  | Capital |  |  | Earnings |  |  | Loss |  |  | Total |
Balances, March 30, 2024 |  |  | 137,538 |  |  | $ | 1,375 |  |  | $ | 521,904 |  |  | $ | 162,763 |  |  | $ | (3,380 | ) |  | $ | 682,662 |
Components of comprehensive income, net of tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the three months ended June 29, 2024 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 22,631 |  |  |  | — |  |  |  | 22,631 |
Other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (296 | ) |  |  | (296 | )
Total comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 22,335 |
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes |  |  | 370 |  |  |  | 4 |  |  |  | 436 |  |  |  | — |  |  |  | — |  |  |  | 440 |
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 3,219 |  |  |  | — |  |  |  | — |  |  |  | 3,219 |
Repurchase of common stock |  |  | (143 | ) |  |  | (1 | ) |  |  | (9,806 | ) |  |  | — |  |  |  | — |  |  |  | (9,807 | )
Balances, June 29, 2024 |  |  | 137,765 |  |  | $ | 1,378 |  |  | $ | 515,753 |  |  | $ | 185,394 |  |  | $ | (3,676 | ) |  | $ | 698,849 |

The following summarizes the changes in total equity for the three-month period ended July 1, 2023:

|  | Common Stock ($.01 par value) |  |  | Additional Paid-in |  |  | Accumulated |  |  | Accumulated Other Comprehensive |  |  |  |  |
(In thousands, except par value data) |  | Shares |  |  | Amount |  |  | Capital |  |  | Deficit |  |  | Loss |  |  | Total |
Balances, April 1, 2023 |  |  | 137,637 |  |  | $ | 1,376 |  |  | $ | 570,994 |  |  | $ | (55,171 | ) |  | $ | (2,225 | ) |  | $ | 514,974 |
Components of comprehensive income, net of tax: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net income for the three months ended July 1, 2023 |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 50,644 |  |  |  | — |  |  |  | 50,644 |
Other comprehensive income (loss) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (457 | ) |  |  | (457 | )
Total comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 50,187 |
Common stock issued in connection with employee equity incentive plans, net of shares withheld for employee taxes |  |  | 308 |  |  |  | 3 |  |  |  | (1,890 | ) |  |  | — |  |  |  | — |  |  |  | (1,887 | )
Stock-based compensation expense |  |  | — |  |  |  | — |  |  |  | 21,489 |  |  |  | — |  |  |  | — |  |  |  | 21,489 |
Repurchase of common stock |  |  | (122 | ) |  |  | (1 | ) |  |  | (10,001 | ) |  |  | — |  |  |  | — |  |  |  | (10,002 | )
Balances, July 1, 2023 |  |  | 137,823 |  |  | $ | 1,378 |  |  | $ | 580,592 |  |  | $ | (4,527 | ) |  | $ | (2,682 | ) |  | $ | 574,761 |

See Accompanying Notes to Unaudited Consolidated Financial Statements.

- 9 -

Table of Contents

LATTICE SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1 - Basis of Presentation

Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses.

Basis of Presentation and Use of Estimates

The accompanying Consolidated Financial Statements are unaudited and have been prepared in accordance with U.S. Generally Accepted Accounting Principles ("U.S. GAAP") and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission ("SEC"). In our opinion, they include all adjustments, consisting only of normal recurring adjustments, necessary for the fair presentation of results for the interim periods. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted as permitted by the SEC's rules and regulations for interim reporting. These Consolidated Financial Statements should be read in conjunction with our audited financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 30, 2023 ("2023 10-K").

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, the actual results that we experience may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.

We describe our accounting methods and practices in more detail in our 2023 10-K. There have been no changes to the significant accounting policies, procedures, or general information described in our 2023 10-K that have had a material impact on our consolidated financial statements and related notes. Certain prior year balances have been reclassified to conform to the current year’s presentation.

Fiscal Reporting Periods

We report based on a 52 or 53-week fiscal year ending on the Saturday closest to December 31. Our fiscal 2024 will be a 52-week year and will end on December 28, 2024, and our fiscal 2023 was a 52-week year that ended December 30, 2023. Our second quarter of fiscal 2024 and second quarter of fiscal 2023 ended on June 29, 2024 and July 1, 2023, respectively. All references to quarterly financial results are references to the results for the relevant 13-week or 26-week fiscal period.

Concentrations of Risk

Potential exposure to concentrations of risk may impact revenue and accounts receivable. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarters of fiscal 2024 and 2023, respectively and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively. Distributors also account for a substantial portion of our net accounts receivable. Our three largest distributors accounted for 44%, 29%, and 12% of net accounts receivable at June 29, 2024 and 36%, 29%, and 18% of net accounts receivable at December 30, 2023.

Note 2 - Net Income per Share

Our calculation of the diluted share count includes the number of shares from our equity awards with market conditions or performance conditions that would be issuable under the terms of such awards at the end of the reporting period. For equity awards with a market condition, the number of shares included in the diluted share count as of the end of each period presented is determined by measuring the achievement of the market condition as of the end of the respective reporting periods. For equity awards with a performance condition, the number of shares that qualified for vesting as of the end of each period presented are included in the diluted share count when the condition for their issuance was satisfied by the end of the respective reporting periods. See "Note 9 - Stock-Based Compensation" to our consolidated financial statements for further discussion of our equity awards with market conditions or performance conditions.

- 10 -

Table of Contents

A summary of basic and diluted Net income per share is presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands, except per share data) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Net income |  | $ | 22,631 |  |  | $ | 50,644 |  |  | $ | 37,427 |  |  | $ | 106,567 |
Shares used in basic Net income per share |  |  | 137,548 |  |  |  | 137,735 |  |  |  | 137,480 |  |  |  | 137,573 |
Dilutive effect of stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition |  |  | 695 |  |  |  | 2,033 |  |  |  | 1,005 |  |  |  | 2,393 |
Shares used in diluted Net income per share |  |  | 138,243 |  |  |  | 139,768 |  |  |  | 138,485 |  |  |  | 139,966 |
Basic Net income per share |  | $ | 0.16 |  |  | $ | 0.37 |  |  | $ | 0.27 |  |  | $ | 0.77 |
Diluted Net income per share |  | $ | 0.16 |  |  | $ | 0.36 |  |  | $ | 0.27 |  |  | $ | 0.76 |

The computation of diluted Net income per share excludes the effects of stock options, restricted stock units ("RSUs"), Employee Stock Purchase Plan ("ESPP") shares, and equity awards with a market condition or performance condition that are antidilutive, aggregating approximately the following number of shares:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Stock options, RSUs, ESPP shares, and equity awards with a market condition or performance condition excluded as they are antidilutive |  |  | 1,001 |  |  |  | 158 |  |  |  | 898 |  |  |  | 115 |

Note 3 - Revenue from Contracts with Customers

Disaggregation of Revenue

The following tables provide information about revenue from contracts with customers disaggregated by channel and by geographical market, based on ship-to location of our customers:

|  | Three Months Ended |  |  | Six Months Ended |
Revenue by Channel |  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Distributors |  | $ | 112,530 |  |  |  | 91 | % |  | $ | 169,362 |  |  |  | 89 | % |  | $ | 235,735 |  |  |  | 89 | % |  | $ | 330,708 |  |  |  | 88 | %
Direct |  |  | 11,546 |  |  |  | 9 | % |  |  | 20,717 |  |  |  | 11 | % |  |  | 29,156 |  |  |  | 11 | % |  |  | 43,681 |  |  |  | 12 | %
Total revenue |  | $ | 124,076 |  |  |  | 100 | % |  | $ | 190,079 |  |  |  | 100 | % |  | $ | 264,891 |  |  |  | 100 | % |  | $ | 374,389 |  |  |  | 100 | %
Revenue by Geographical Market |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
(In thousands) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
China |  | $ | 48,159 |  |  |  | 39 | % |  | $ | 55,834 |  |  |  | 30 | % |  | $ | 105,031 |  |  |  | 40 | % |  | $ | 111,556 |  |  |  | 30 | %
Japan |  |  | 23,161 |  |  |  | 19 | % |  |  | 38,728 |  |  |  | 20 | % |  |  | 48,149 |  |  |  | 18 | % |  |  | 68,745 |  |  |  | 18 | %
Other Asia |  |  | 11,299 |  |  |  | 9 | % |  |  | 24,461 |  |  |  | 13 | % |  |  | 21,867 |  |  |  | 8 | % |  |  | 44,477 |  |  |  | 12 | %
Asia |  |  | 82,619 |  |  |  | 67 | % |  |  | 119,023 |  |  |  | 63 | % |  |  | 175,047 |  |  |  | 66 | % |  |  | 224,778 |  |  |  | 60 | %
Americas |  |  | 23,609 |  |  |  | 19 | % |  |  | 32,668 |  |  |  | 17 | % |  |  | 55,589 |  |  |  | 21 | % |  |  | 74,571 |  |  |  | 20 | %
Europe |  |  | 17,848 |  |  |  | 14 | % |  |  | 38,388 |  |  |  | 20 | % |  |  | 34,255 |  |  |  | 13 | % |  |  | 75,040 |  |  |  | 20 | %
Total revenue |  | $ | 124,076 |  |  |  | 100 | % |  | $ | 190,079 |  |  |  | 100 | % |  | $ | 264,891 |  |  |  | 100 | % |  | $ | 374,389 |  |  |  | 100 | %

- 11 -

Table of Contents

Contract Balances

Our contract assets relate to our rights to consideration for licenses and royalties due to us as a member of the HDMI Founders consortium. The balance results primarily from the amount of estimated revenue related to HDMI that we have recognized to date, but which has not yet been distributed to us by the HDMI licensing agent. Contract assets are included in Prepaid expenses and other current assets on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:

(In thousands) |  |  |  |
Contract assets as of December 30, 2023 |  | $ | 11,194 |
Revenues recorded during the period |  |  | 7,646 |
Transferred to Accounts receivable or collected |  |  | (4,663 | )
Contract assets as of June 29, 2024 |  | $ | 14,177 |

Contract liabilities are included in Accrued liabilities on our Consolidated Balance Sheets. The following table summarizes activity during the first six months of fiscal 2024:

(In thousands) |  |  |  |
Contract liabilities as of December 30, 2023 |  | $ | 5,304 |
Accruals for estimated future stock rotation and scrap returns |  |  | 9,576 |
Less: Release of accruals for recognized stock rotation and scrap returns |  |  | (8,929 | )
Contract liabilities as of June 29, 2024 |  | $ | 5,951 |

Note 4 - Balance Sheet Components

Accounts Receivable

Accounts receivable do not bear interest and are shown net of an allowance for expected lifetime credit losses, which reflects our best estimate of probable losses inherent in the accounts receivable balance, as described in our 2023 10-K.

|  | June 29, |  |  | December 30, |
(In thousands) |  | 2024 |  |  | 2023 |
Accounts receivable |  | $ | 103,442 |  |  | $ | 104,373 |
Less: Allowance for credit losses |  |  | — |  |  |  | — |
Accounts receivable, net of allowance for credit losses |  | $ | 103,442 |  |  | $ | 104,373 |

Inventories

|  | June 29, |  |  | December 30, |
(In thousands) |  | 2024 |  |  | 2023 |
Work in progress |  | $ | 69,659 |  |  | $ | 65,396 |
Finished goods |  |  | 31,897 |  |  |  | 33,430 |
Total inventories, net |  | $ | 101,556 |  |  | $ | 98,826 |

Property and Equipment – Geographic Information

Our Property and equipment, net by country at the end of each period was as follows:

|  | June 29, |  |  | December 30, |
(In thousands) |  | 2024 |  |  | 2023 |
United States |  | $ | 31,833 |  |  | $ | 29,467 |
Taiwan |  |  | 8,146 |  |  |  | 10,222 |
Philippines |  |  | 5,153 |  |  |  | 4,602 |
China |  |  | 2,758 |  |  |  | 2,778 |
Other |  |  | 2,911 |  |  |  | 2,477 |
Total foreign property and equipment, net |  |  | 18,968 |  |  |  | 20,079 |
Total property and equipment, net |  | $ | 50,801 |  |  | $ | 49,546 |

- 12 -

Table of Contents

Accrued Liabilities

Included in Accrued liabilities in the Consolidated Balance Sheets are the following balances:

|  | June 29, |  |  | December 30, |
(In thousands) |  | 2024 |  |  | 2023 |
Liability for non-cancelable contracts |  | $ | 8,977 |  |  | $ | 11,418 |
Current portion of operating lease liabilities |  |  | 7,249 |  |  |  | 5,571 |
Contract liabilities |  |  | 5,951 |  |  |  | 5,304 |
Foreign, VAT, and other taxes payable |  |  | 3,909 |  |  |  | 6,758 |
Other accrued liabilities |  |  | 6,002 |  |  |  | 6,997 |
Total accrued liabilities |  | $ | 32,088 |  |  | $ | 36,048 |

Note 5 - Long-Term Debt

On September 1, 2022, we entered into an Amended and Restated Credit Agreement (the “2022 Credit Agreement”), which provides for a five-year secured revolving loan facility with an aggregate principal amount of up to $350 million.

The revolving loans under the 2022 Credit Agreement may be repaid and reborrowed at our discretion, with any remaining outstanding principal amount due and payable on the maturity date of the revolving loan on September 1, 2027. At June 29, 2024 and December 30, 2023, we had no borrowings outstanding under the 2022 Credit Agreement, as we paid off the outstanding balance of our revolving loans during the third quarter of fiscal 2023.

We pay a quarterly commitment fee of 0.20% on the unused portion of the revolving facility. Interest expense related to our long-term debt was included in Interest expense on our Consolidated Statements of Operations as follows:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Contractual interest |  | $ | - |  |  | $ | 832 |  |  | $ | - |  |  | $ | 2,618 |
Amortization of original issuance discount and debt costs |  |  | 67 |  |  |  | 67 |  |  |  | 133 |  |  |  | 133 |
Total interest expense related to long-term debt |  | $ | 67 |  |  | $ | 899 |  |  | $ | 133 |  |  | $ | 2,751 |

- 13 -

Table of Contents

Note 6 - Restructuring

Under the Q3 2023 Plan, which is described in the 2023 10-K, we incurred restructuring costs of approximately $2.7 million and approximately $5.0 million during the second quarter and first six months, respectively, of fiscal 2024. Under this plan, approximately $7.0 million of total costs have been incurred through June 29, 2024. The Q3 2023 plan is expected to be largely complete by the end of fiscal year 2024.

Other restructuring activity in the periods presented consisted of expense adjustments on previous plans. Costs and adjustments on restructuring plans are recorded to Restructuring on our Consolidated Statements of Operations. The restructuring accrual balance is presented in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets. The following table displays the activity related to our restructuring plans:

(In thousands) |  | Severance & Related (1) |  |  | Lease Termination & Fixed Assets |  |  | Other (2) |  |  | Total |
Accrued Restructuring at December 30, 2023 |  | $ | 1,490 |  |  | $ | 4,508 |  |  | $ | 620 |  |  | $ | 6,618 |
Restructuring |  |  | 5,001 |  |  |  | (98 | ) |  |  | (620 | ) |  |  | 4,283 |
Costs paid or otherwise settled |  |  | (3,713 | ) |  |  | (652 | ) |  |  | — |  |  |  | (4,365 | )
Accrued Restructuring at June 29, 2024 |  | $ | 2,778 |  |  | $ | 3,758 |  |  | $ | — |  |  | $ | 6,536 |
Accrued Restructuring at December 31, 2022 |  | $ | 400 |  |  | $ | 5,892 |  |  | $ | 640 |  |  | $ | 6,932 |
Restructuring |  |  | (135 | ) |  |  | 49 |  |  |  | 4 |  |  |  | (82 | )
Costs paid or otherwise settled |  |  | (265 | ) |  |  | (721 | ) |  |  | (24 | ) |  |  | (1,010 | )
Accrued Restructuring at July 1, 2023 |  | $ | — |  |  | $ | 5,220 |  |  | $ | 620 |  |  | $ | 5,840 |

(1) | Includes employee relocation and outplacement costs
(2) | Includes termination fees on the cancellation of certain contracts

Note 7 - Leases

We have operating leases for corporate offices, sales offices, research and development facilities, storage facilities, and a data center. All of our facilities are leased under operating leases, which expire at various times through 2029, with a weighted-average remaining lease term of 3.2 years and a weighted-average discount rate of 6.0% as of June 29, 2024.

We recorded fixed operating lease expenses of $2.2 million and $1.9 million for the second quarter of fiscal 2024 and 2023, respectively, and $4.3 million and $3.8 million for the first six months of fiscal 2024 and 2023, respectively.

The following table presents the lease balance classifications within the Consolidated Balance Sheets and summarizes their activity during the first six months of fiscal 2024:

Operating lease right-of-use assets |  | (In thousands) |
Balance as of December 30, 2023 |  | $ | 14,487 |
Right-of-use assets obtained for new lease contracts during the period |  |  | 7,162 |
Amortization of right-of-use assets during the period |  |  | (3,812 | )
Impairment of right-of use asset during the period (recorded in Restructuring charges) |  |  | (384 | )
Adjustments for present value and foreign currency effects |  |  | (127 | )
Balance as of June 29, 2024 |  | $ | 17,326 |

Operating lease liabilities |  | (In thousands) |
Balance as of December 30, 2023 |  | $ | 16,310 |
Lease liabilities incurred for new lease contracts during the period |  |  | 7,162 |
Accretion of lease liabilities |  |  | 526 |
Operating cash used for payments on lease liabilities |  |  | (4,564 | )
Adjustments for present value and foreign currency effects |  |  | (210 | )
Balance as of June 29, 2024 |  |  | 19,224 |
Less: Current portion of operating lease liabilities (included in Accrued liabilities) |  |  | (7,249 | )
Long-term operating lease liabilities, net of current portion |  | $ | 11,975 |

- 14 -

Table of Contents

Maturities of operating lease liabilities as of June 29, 2024 are as follows:

Fiscal year |  | (In thousands) |
2024 (Remaining 2 quarters) |  | $ | 4,270 |
2025 |  |  | 6,744 |
2026 |  |  | 4,580 |
2027 |  |  | 2,804 |
2028 |  |  | 2,226 |
Thereafter |  |  | 446 |
Total lease payments |  |  | 21,070 |
Less: amount representing interest |  |  | (1,846 | )
Total lease liabilities |  | $ | 19,224 |

Lease obligations for facilities restructured prior to the adoption of Topic 842 totaled approximately $3.8 million at June 29, 2024 and is recorded in Accrued liabilities and in Other long-term liabilities on our Consolidated Balance Sheets.

Note 8 - Intangible Assets

In connection with our past acquisitions, we have recorded identifiable intangible assets. On our Consolidated Balance Sheets at June 29, 2024 and December 30, 2023, Intangible assets, net are shown net of accumulated amortization of $147.1 million and $144.9 million, respectively. Additionally, we enter into license agreements for third-party technology and record them as intangible assets. These licenses are being amortized to Research and development expense over their estimated useful lives.

We recorded amortization expense related to intangible assets on the Consolidated Statements of Operations as presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Research and development |  | $ | 247 |  |  | $ | 271 |  |  | $ | 513 |  |  | $ | 541 |
Amortization of acquired intangible assets |  |  | 869 |  |  |  | 869 |  |  |  | 1,739 |  |  |  | 1,739 |
|  | $ | 1,116 |  |  | $ | 1,140 |  |  | $ | 2,252 |  |  | $ | 2,280 |

Note 9 - Stock-Based Compensa tion

Total stock-based compensation expense included in our Consolidated Statements of Operations is presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Cost of revenue |  | $ | 800 |  |  | $ | 1,414 |  |  | $ | 1,655 |  |  | $ | 2,367 |
Research and development |  |  | 5,865 |  |  |  | 7,647 |  |  |  | 13,963 |  |  |  | 12,986 |
Selling, general, and administrative |  |  | (3,446 | ) |  |  | 12,428 |  |  |  | 6,095 |  |  |  | 20,391 |
Total stock-based compensation |  | $ | 3,219 |  |  | $ | 21,489 |  |  | $ | 21,713 |  |  | $ | 35,744 |

Market-Based and Performance-Based Stock Compensation

In the first quarter of fiscal 2024, we granted awards of RSUs with a market condition to certain executives. Under the terms of these grants, the RSUs with a market condition vest after a three-year period based on the Company’s total shareholder return ("TSR") relative to the Russell 3000 index, which condition is measured for the grants on the third anniversary of the grant date. The awards may vest at 250% or 200%, depending on the executive, if the 75th percentile of the market condition is achieved, with 100% of the units vesting at the 55th percentile, zero vesting if relative TSR is below the 25th percentile, and vesting scaling for achievement between the 25th and 75th percentile.

- 15 -

Table of Contents

In the second quarter of fiscal 2024, we also granted awards of RSUs with a performance condition to certain executives. Under the terms of these grants, the RSUs with a performance condition will vest if the Company achieves year-over-year revenue growth in excess of an industry benchmark, and the number of shares vested will scale for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 250%. The performance condition will be measured annually after each fiscal year-end for one-fourth of the grants beginning in fiscal 2025 through the end of fiscal 2028. Vesting of these awards occurs 13 months after the end of each measurement period and the entire award cannot be fully earned until five and a half years from grant date.

In the first six months of fiscal 2024, certain awards with a market condition or performance condition granted in prior fiscal years vested. During the first quarter of fiscal 2024, the market condition for awards granted to certain executives in the first quarter of fiscal 2021 exceeded the 75th percentile of their TSR condition, and these awards vested at 250% or 200%, as applicable for the respective executive. Also during the first quarter of fiscal 2024, the second tranche of awards granted in fiscal 2021 and 2022 with a performance condition vested. Under the terms of these grants, the RSUs with a performance condition will vest based on the Company generating specified levels of year-over-year revenue growth, which are measured annually for one-fourth of the grants after each fiscal year-end through the end of fiscal 2024, with vesting of each tranche occurring 13 months after the performance condition is met. Vesting of these awards scales for achievement of year-over-year revenue growth compared to certain targets, with maximum vesting up to 200%. The second tranche of these awards vested at the 200% level of achievement, as the Company met the maximum year-over-year revenue growth performance criteria as of December 31, 2022. For the third tranche of these awards, the Company met the year-over-year revenue growth performance criteria at the 116.3% level of achievement as of December 30, 2023.

For our awards with a market condition or a performance condition, we recorded benefits from forfeitures of approximately $15.1 million in the second quarter of fiscal 2024 due to executive departures, which was partially offset by stock compensation expense of approximately $6.1 million and $12.0 million in the second quarter and first six months of fiscal 2024, respectively, and we incurred stock compensation expense of approximately $11.0 million and $15.9 million in the second quarter and first six months of fiscal 2023, respectively, which are recorded as components of total stock-based compensation.

The following table summarizes the activity for our awards with a market condition or performance condition:

(Shares in thousands) |  | Total |
Balance, December 30, 2023 |  |  | 852 |
Granted |  |  | 772 |
Effect of vesting multiplier |  |  | 284 |
Vested |  |  | (541 | )
Canceled |  |  | (332 | )
Balance, June 29, 2024 |  |  | 1,035 |

Note 10 - Common Stock Repurchase Program

On November 30, 2023, we announced that our Board of Directors had approved a stock repurchase program pursuant to which up to $250 million of outstanding common stock could be repurchased from time to time (the "2024 Repurchase Program"). The duration of the 2024 Repurchase Program is through December 28, 2024.

During the second quarter of fiscal 2024, we repurchased 143,402 shares for $10.0 million, or an average price paid per share of $69.73, under the 2024 Repurchase Program. During the first six months of fiscal 2024, we have repurchased a total of 408,282 shares for $30.0 million, or an average price paid per share of $73.48. All repurchases were open market transactions funded from available working capital. All shares repurchased pursuant to the 2024 Repurchase Program were retired by the end of the second quarter of fiscal 2024. As of June 29, 2024, the remaining portion of the amount authorized for the 2024 Repurchase Program is approximately $220.0 million.

- 16 -

Table of Contents

Note 11 - Income Taxes

We are subject to federal and state income tax as well as income tax in the foreign jurisdictions in which we operate. For the second quarter of fiscal 2024 and 2023, we recorded income tax expense of approximately $1.1 million and $2.4 million, respectively. For the first six months of fiscal 2024 and 2023, we recorded income tax expense of approximately $4.2 million and $5.0 million, respectively. Income taxes for the three- and six-month periods ended June 29, 2024 and July 1, 2023 represent tax at the federal, state, and foreign statutory tax rates in addition to federal tax credits, withholding taxes, excess benefits from stock compensation, as well as other non-deductible items in federal, state, and foreign jurisdictions. The difference between the U.S. federal statutory tax rate of 21% and our effective tax rates for the three and six months ended June 29, 2024 resulted primarily from non-deductible items in federal, state, and foreign jurisdictions, foreign rate differentials, federal tax credits, and the discrete impacts of excess tax benefits from stock compensation and for the three and six months ended July 1, 2023 resulted primarily from U.S. valuation allowance, foreign withholding taxes, foreign rate differentials, and the discrete impacts of excess tax benefits from stock compensation.

The portion of our uncertain tax positions (including penalties and interest) recorded as a liability was $22.3 million and $21.9 million at June 29, 2024 and December 30, 2023, respectively, and is included as a component of Other long-term liabilities on our Consolidated Balance Sheets. The resolution of audits or expiration of statute of limitations could reduce our uncertain tax positions. The estimated potential reduction in our uncertain tax positions in the next 12 months is up to $36.0 million.

Note 12 - Contingencies

Legal Proceedings

On or about December 19, 2018, Steven De Jaray, Perienne De Jaray and Darrell Oswald (collectively, the “Plaintiffs”) commenced an action against the Company in the Multnomah County Circuit Court of the State of Oregon, in connection with the sale of certain products by the Company to the Plaintiffs in or around 2008. The Plaintiffs alleged the Company violated the Lanham Act, engaged in negligence, fraud, and breach of contract by failing to disclose to the Plaintiffs the export-controlled status of the subject parts. In January 2019, we removed the action to the United States District Court for the District of Oregon (the “Court”). On May 24, 2023, the Plaintiffs filed a second amended complaint, which added Apex-Micro Manufacturing Corporation (“Apex-Micro”) as a plaintiff and removed the violation of the Lanham Act claim. The Plaintiffs sought damages of $180 million, punitive damages, and other remedies. On January 18, 2024, the court dismissed the claims against the Company by Ms. De Jaray and Mr. Oswald. The trial for the remaining claims was held from January 30, 2024 to February 15, 2024. On February 13, 2024, the Court granted the Company’s Rule 50 motion in part and entered judgment in the Company’s favor as to all of Mr. De Jaray’s claims and Apex-Micro’s negligence claims. On February 15, 2024, the jury found that the Company was not liable for all outstanding claims and judgment was entered in favor of the Company. On March 15, 2024, Mr. De Jaray and Apex-Micro filed a Notice of Appeal to the United States Court of Appeals for the Ninth Circuit. On March 18, 2024, Ms. De Jaray filed a separate Notice of Appeal. In response to plaintiff's request for an extension, the plaintiffs’ appeal opening brief is now due October 7, 2024. The Company will file an appeal answering brief.

From time to time, we are exposed to certain additional asserted and unasserted potential claims. We review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and a range of possible losses can be estimated, we then accrue a liability for the estimated loss. Legal proceedings are subject to uncertainties, and the outcomes are difficult to predict. Because of such uncertainties, accruals are based only on the best information available at the time. As additional information becomes available, we reassess the potential liability related to pending claims and litigation and may revise estimates.

- 17 -

Table of Contents

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion should be read along with the unaudited consolidated financial statements and notes thereto included in Part I, Item 1 of this Quarterly Report on Form 10-Q, as well as the audited consolidated financial statements and notes thereto and Management’s Discussion and Analysis of Financial Condition and Results of Operations in our 2023 10-K.

Overview

Lattice Semiconductor Corporation and its subsidiaries (“Lattice,” the “Company,” “we,” “us,” or “our”) develop technologies that we monetize through differentiated programmable logic semiconductor products, silicon-enabling products, system solutions, design services, and technology licenses. Lattice is the low power programmable leader. We solve customer problems across the network, from the Edge to the Cloud, in the Communications, Computing, Industrial, Automotive, and Consumer markets. Our technology, long-standing relationships, and commitment to world-class support helps our customers quickly and easily unleash their innovation to create a smart, secure, and connected world.

Lattice has focused its strategy on delivering programmable logic products and related solutions based on low power, small size, and ease of use. We also serve our customers with intellectual property ("IP") licensing and various other services. Our product development activities include new proprietary products, advanced packaging, existing product enhancements, software development tools, soft IP, and system solutions for high-growth applications such as Edge Artificial Intelligence, wireless and wireline infrastructure, platform security, and factory automation.

Critical Accounting Policies and Use of Estimates

Critical accounting policies are those that are both most important to the portrayal of a company's financial condition and results of operations, and that require management's most difficult, subjective, and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. There have been no material changes to the items that we disclosed as our critical accounting policies and estimates in Management's Discussion and Analysis of Financial Condition and Results of Operations in our 2023 10-K.

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and judgments affecting the amounts reported in our consolidated condensed financial statements and the accompanying notes. We base our estimates and judgments on historical experience, knowledge of current conditions, and our beliefs of what could occur in the future considering available information. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when made, and because of the uncertainty inherent in these matters, actual results may differ materially from these estimates under different assumptions or conditions. We evaluate our estimates and judgments on an ongoing basis.

Impact of Global Economic Activity on our Business

Increased financial market volatility, inflationary pressure, interest rate changes, recessionary concerns, uncertainty in the financial and banking industry, and geopolitical tension continue to impact business globally and may impact our operations by causing disruption to our labor markets and supply chains. The extent to which increased financial market volatility, inflationary pressures, global pandemics, and related uncertainty will impact our business activities will depend on future developments that are highly uncertain and cannot be predicted at this time. Additionally, our business is impacted by the cyclic correction affecting the broader semiconductor industry, which has seen softened demand across our end markets.

- 18 -

Table of Contents

Results of Operations

Key elements of our Consolidated Statements of Operations, including as a percentage of revenue, are presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Revenue |  | $ | 124,076 |  |  |  | 100.0 | % |  | $ | 190,079 |  |  |  | 100.0 | % |  | $ | 264,891 |  |  |  | 100.0 | % |  | $ | 374,389 |  |  |  | 100.0 | %
Gross margin |  |  | 84,751 |  |  |  | 68.3 |  |  |  | 132,561 |  |  |  | 69.7 |  |  |  | 180,959 |  |  |  | 68.3 |  |  |  | 261,162 |  |  |  | 69.8 |
Research and development |  |  | 38,733 |  |  |  | 31.2 |  |  |  | 41,946 |  |  |  | 22.1 |  |  |  | 79,324 |  |  |  | 29.9 |  |  |  | 77,935 |  |  |  | 20.8 |
Selling, general and, administrative |  |  | 20,005 |  |  |  | 16.1 |  |  |  | 36,788 |  |  |  | 19.4 |  |  |  | 56,474 |  |  |  | 21.3 |  |  |  | 69,366 |  |  |  | 18.5 |
Amortization of acquired intangible assets |  |  | 869 |  |  |  | 0.7 |  |  |  | 869 |  |  |  | 0.5 |  |  |  | 1,739 |  |  |  | 0.7 |  |  |  | 1,739 |  |  |  | 0.5 |
Restructuring |  |  | 2,579 |  |  |  | 2.1 |  |  |  | (112 | ) |  |  | (0.1 | ) |  |  | 4,283 |  |  |  | 1.6 |  |  |  | (82 | ) |  |  | (0.0 | )
Income from operations |  | $ | 22,565 |  |  |  | 18.2 | % |  | $ | 53,070 |  |  |  | 27.9 | % |  | $ | 39,139 |  |  |  | 14.8 | % |  | $ | 112,204 |  |  |  | 30.0 | %

Revenue by End Market

We sell our products globally to a broad base of customers in three primary end market groups: Communications and Computing, Industrial and Automotive, and Consumer. Across our end markets, our products are increasingly used for Artificial Intelligence ("AI")-related applications, including device usage in AI-optimized servers in data centers, AI-enabled PCs, and AI-enabled robotics and ADAS systems, among others. We also provide IP licensing and services to these end markets.

Within these end markets, there are multiple drivers, including:

• | Communications and computing: data center servers and networking equipment, client computing platforms, and wireless and wireline communications infrastructure deployments,
• | Industrial and automotive: factory automation, robotics, automotive electronics, and industrial Internet of Things ("IoT"),
• | Consumer: smart home, prosumer, and other applications.

The end market data we use is derived from data provided to us by our distributors and end customers. With a diverse base of customers who may manufacture end products spanning multiple end markets, the assignment of revenue to a specific end market requires the use of judgment. We also recognize certain revenue for which end customers and end markets are not yet known. We assign this revenue first to a specific end market using historical and anticipated usage of the specific products, if possible, and allocate the remainder to the end markets based on either historical usage for each product family or industry application data for certain product types.

The following are examples of end market applications for the periods presented:

Communications and Computing | Industrial and Automotive | Consumer
Wireless | Security and Surveillance | Cameras
Wireline | Machine Vision | Displays
Data Networking | Industrial Automation | Wearables
Server Computing | Robotics | Televisions
Client Computing | Automotive | Home Theater
Data Storage | Drones |

- 19 -

Table of Contents

The composition of our revenue by end market is presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Communications and Computing |  | $ | 54,528 |  |  |  | 44.0 | % |  | $ | 64,220 |  |  |  | 33.8 | % |  | $ | 109,147 |  |  |  | 41.2 | % |  | $ | 130,565 |  |  |  | 34.9 | %
Industrial and Automotive |  |  | 58,246 |  |  |  | 46.9 |  |  |  | 115,496 |  |  |  | 60.8 |  |  |  | 133,511 |  |  |  | 50.4 |  |  |  | 223,769 |  |  |  | 59.8 |
Consumer |  |  | 11,302 |  |  |  | 9.1 |  |  |  | 10,363 |  |  |  | 5.4 |  |  |  | 22,233 |  |  |  | 8.4 |  |  |  | 20,055 |  |  |  | 5.3 |
Total revenue |  | $ | 124,076 |  |  |  | 100.0 | % |  | $ | 190,079 |  |  |  | 100.0 | % |  | $ | 264,891 |  |  |  | 100.0 | % |  | $ | 374,389 |  |  |  | 100.0 | %

Revenue from the Communications and Computing end market decreased by 15% for the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 16% for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 primarily due to weaker demand in telecommunications infrastructure deployments and end customers rebalancing their inventory levels, partially offset by stronger demand in data center applications.

Revenue from the Industrial and Automotive end market decreased by 50% for the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 40% for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 primarily due to softer end market demand and end customers rebalancing their inventory levels.

While we do not consider AI applications as a distinct end market, we expect AI-related revenue to grow over the next few years based on the growing pipeline of AI-related design wins.

Revenue by Geography

We have a diverse base of customers where distributors represent a significant portion of our total revenue. Our revenue by geographical market is based on the ship-to location of our customers, which can vary from time to time. Revenue from Asia decreased in the periods presented primarily due to the macroeconomic environment in the region, while revenue from the Americas and Europe decreased due to reduced demand in these regions for our products in the Industrial and Automotive end market.

The composition of our revenue by geography is presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Asia |  | $ | 82,619 |  |  |  | 66.6 | % |  | $ | 119,023 |  |  |  | 62.6 | % |  | $ | 175,047 |  |  |  | 66.1 | % |  | $ | 224,778 |  |  |  | 60.1 | %
Americas |  |  | 23,609 |  |  |  | 19.0 |  |  |  | 32,668 |  |  |  | 17.2 |  |  |  | 55,589 |  |  |  | 21.0 |  |  |  | 74,571 |  |  |  | 19.9 |
Europe |  |  | 17,848 |  |  |  | 14.4 |  |  |  | 38,388 |  |  |  | 20.2 |  |  |  | 34,255 |  |  |  | 12.9 |  |  |  | 75,040 |  |  |  | 20.0 |
Total revenue |  | $ | 124,076 |  |  |  | 100.0 | % |  | $ | 190,079 |  |  |  | 100.0 | % |  | $ | 264,891 |  |  |  | 100.0 | % |  | $ | 374,389 |  |  |  | 100.0 | %

Revenue from Customers

We sell our products to independent distributors and directly to customers. Distributors have historically accounted for a significant portion of our total revenue. Revenue attributable to distributors as a percentage of total revenue was 91% and 89% for the second quarter of fiscal 2024 and 2023, respectively, and 89% and 88% for the first six months of fiscal 2024 and 2023, respectively.

Gross Margin

The composition of our Gross margin, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  | Six Months Ended |
|  | June 29, |  |  | July 1, |  |  | June 29, |  |  | July 1, |
(In thousands) |  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Gross margin |  | $ | 84,751 |  |  | $ | 132,561 |  |  | $ | 180,959 |  |  | $ | 261,162 |
Gross margin percentage |  |  | 68.3 | % |  |  | 69.7 | % |  |  | 68.3 | % |  |  | 69.8 | %

Gross margin, as a percentage of revenue, decreased 140 basis points in the second quarter of fiscal 2024 compared to the second quarter of fiscal 2023 and decreased by 150 basis points for the first six months of fiscal 2024 compared to the first six months of fiscal 2023. Reduced margins were primarily due to changes in product mix between the periods presented.

- 20 -

Table of Contents

Operating Expenses

Research and Development Expense

The composition of our Research and development expense, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Research and development |  | $ | 38,733 |  |  | $ | 41,946 |  |  |  | (7.7 | )% |  | $ | 79,324 |  |  | $ | 77,935 |  |  |  | 1.8 | %
Percentage of revenue |  |  | 31.2 | % |  |  | 22.1 | % |  |  |  |  |  |  | 29.9 | % |  |  | 20.8 | % |  |  |  |

Research and development expense includes costs for compensation and benefits, stock-based compensation, engineering wafers, depreciation and amortization, licenses, and outside engineering services. These expenditures are for the design of new products, IP cores, processes, packaging, and software solutions. The decrease in Research and development expense for the second quarter of fiscal2024 compared to the second quarter of fiscal 2023 was due primarily to lower headcount-related costs, including stock-based compensation. The increase in Research and development expense for the first six months of fiscal 2024 compared to the first six months of fiscal 2023 was due primarily to higher depreciation and amortization related to our research and development equipment and tools. We believe that investing in research and development is important to delivering innovative products to our customers.

Selling, General, and Administrative Expense

The composition of our Selling, general, and administrative expense, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Selling, general, and administrative |  | $ | 20,005 |  |  | $ | 36,788 |  |  |  | (45.6 | )% |  | $ | 56,474 |  |  | $ | 69,366 |  |  |  | (18.6 | )%
Percentage of revenue |  |  | 16.1 | % |  |  | 19.4 | % |  |  |  |  |  |  | 21.3 | % |  |  | 18.5 | % |  |  |  |

Selling, general, and administrative expense includes costs for compensation and benefits related to selling, general, and administrative employees, commissions, depreciation, professional and outside services, trade show, and travel expenses. The decrease in Selling, general, and administrative expense for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was primarily due to the benefits to stock compensation expense from the forfeiture of equity awards by departing executives, partially offset by other costs such as legal expenses.

Amortization of Acquired Intangible Assets

The composition of our Amortization of acquired intangible assets, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Amortization of acquired intangible assets |  | $ | 869 |  |  | $ | 869 |  |  |  | — | % |  | $ | 1,739 |  |  | $ | 1,739 |  |  |  | — | %
Percentage of revenue |  |  | 0.7 | % |  |  | 0.5 | % |  |  |  |  |  |  | 0.7 | % |  |  | 0.5 | % |  |  |  |

Amortization of acquired intangible assets was flat between the second quarter and first six months of fiscal 2024 and the second quarter and first six months of fiscal 2023.

- 21 -

Table of Contents

Restructuring

The composition of our Restructuring activity, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Restructuring |  | $ | 2,579 |  |  | $ | (112 | ) |  |  | 100+% |  |  | $ | 4,283 |  |  | $ | (82 | ) |  |  | 100+% |
Percentage of revenue |  |  | 2.1 | % |  |  | (0.1 | )% |  |  |  |  |  |  | 1.6 | % |  |  | (0.0 | )% |  |  |  |

Restructuring activity is generally comprised of expenses resulting from workforce reductions, cancellation of contracts, and consolidation of our facilities. Details of our restructuring plans and expenses incurred under them are discussed in "Note 6 - Restructuring" to our Consolidated Financial Statements in Part I, Item 1 of this Quarterly Report on Form 10-Q. Restructuring costs increased in the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 primarily due to higher costs in the current year periods for severance as compared to minimal restructuring activity in the prior year periods.

Interest Income (Expense), net

The composition of our Interest expense, net, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Interest income (expense), net |  | $ | 933 |  |  | $ | 189 |  |  |  | 100+% |  |  | $ | 2,240 |  |  | $ | (366 | ) |  |  | 100+% |
Percentage of revenue |  |  | 0.8 | % |  |  | 0.1 | % |  |  |  |  |  |  | 0.8 | % |  |  | (0.1 | )% |  |  |  |

The change in Interest income (expense) for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was driven by increased interest income, coupled with decreased interest expense as we paid off the outstanding balance of our long-term debt during the third quarter of fiscal 2023.

Other Income (Expense), net

The composition of our Other income (expense), net, including as a percentage of revenue, is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Other income (expense), net |  | $ | 254 |  |  | $ | (176 | ) |  |  | 100+% |  |  | $ | 208 |  |  | $ | (271 | ) |  |  | 100+% |
Percentage of revenue |  |  | 0.2 | % |  |  | (0.1 | )% |  |  |  |  |  |  | 0.1 | % |  |  | (0.1 | )% |  |  |  |

The change in Other income (expense) for the second quarter and first six months of fiscal 2024 compared to the second quarter and first six months of fiscal 2023 was primarily due to foreign currency effects.

- 22 -

Table of Contents

Income Tax Expense

The composition of our Income tax expense is presented in the following table:

|  | Three Months Ended |  |  |  |  |  |  | Six Months Ended |  |  |  |  |
|  | June 29, |  |  | July 1, |  |  |  |  |  |  | June 29, |  |  | July 1, |  |  |  |  |
(In thousands) |  | 2024 |  |  | 2023 |  |  | % change |  |  | 2024 |  |  | 2023 |  |  | % change |
Income tax (benefit) expense |  | $ | 1,121 |  |  | $ | 2,439 |  |  |  | (54.0 | )% |  | $ | 4,160 |  |  | $ | 5,000 |  |  |  | (16.8 | )%

Our Income tax expense is partially offset by federal tax credits and excess tax benefits from stock-based compensation. The lower income tax expense for the current year periods was primarily due to decreased worldwide income, partially offset by the valuation allowance over the federal deferred tax assets present during 2023.

Liquidity and Capital Resources

The following sections discuss material changes in our financial condition from the end of fiscal 2023, including the effects of changes in our Consolidated Balance Sheets, and the effects of our credit arrangements and contractual obligations on our liquidity and capital resources. There continues to be uncertainty around the extent of market volatility, inflationary pressures, interest rate changes, recessionary concerns, uncertainty in the financial and banking industry, and geopolitical tension, which may impact our liquidity and working capital needs in future periods.

We have historically financed our operating and capital resource requirements through cash flows from operations, and from the issuance of long-term debt to fund acquisitions. Cash provided by or used in operating activities will fluctuate from period to period due to fluctuations in operating results, the timing and collection of accounts receivable, and required inventory levels, among other things.

We believe that our financial resources, including current cash and cash equivalents, cash flow from operating activities, and our credit facilities, will be sufficient to meet our liquidity and working capital needs through at least the next 12 months. On September 1, 2022, we entered into our 2022 Credit Agreement, as described in "Note 5 - Long-Term Debt" under Part I, Item 1 of this report. As of June 29, 2024, we did not have significant long-term commitments for capital expenditures. For further information on our cash commitments for operating lease liabilities, see "Note 7 - Leases" under Part I, Item 1 of this report.

In the future, we may continue to consider acquisition opportunities to further extend our product or technology portfolios and further expand our product offerings. In connection with funding capital expenditures, acquisitions, securing additional wafer supply, increasing our working capital, or other operations, we may seek to obtain equity or additional debt financing. We may also seek to obtain equity or additional debt financing if we experience downturns or cyclical fluctuations in our business that are more severe or longer than we anticipated when determining our current working capital needs.

Cash and cash equivalents

(In thousands) |  | June 29, 2024 |  |  | December 30, 2023 |  |  | $ Change |  |  | % Change |
Cash and cash equivalents |  | $ | 109,216 |  |  | $ | 128,317 |  |  | $ | (19,101 | ) |  |  | (14.9 | )%

As of June 29, 2024, we had Cash and cash equivalents of $109.2 million, of which approximately $43.1 million was held by our foreign subsidiaries. We manage our global cash requirements considering, among other things, (i) available funds among our subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances. The repatriation of non-US earnings may require us to withhold and pay foreign income tax on dividends. This should not result in our recording significant additional tax expense as we have accrued expense based on current withholding rates. As of June 29, 2024, we could access all cash held by our foreign subsidiaries without incurring significant additional expense.

The net decrease in Cash and cash equivalents of $19.1 million between December 30, 2023 and June 29, 2024 was primarily driven by cash flows from the following activities:

- 23 -

Table of Contents

Operating activities — Cash provided by operating activities results from net income adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities for the first six months of fiscal 2024 was $51.4 million compared to $115.5 million for the first six months of fiscal 2023. This decrease of $64.1 million was primarily driven by $80.5 million less cash provided by net income adjusted for non-cash items, partially offset by $16.4 million of net changes in working capital, primarily in Accrued liabilities and Accrued payroll obligations.

Investing activities — Investing cash flows consist primarily of transactions related to capital expenditures and payments for software and intellectual property licenses. Net cash used by investing activities in the first six months of fiscal 2024 was $18.2 million compared to $17.7 million in the first six months of fiscal 2023.

Financing activities — Financing cash flows consist primarily of activity on our long-term debt, repurchases of common stock, tax payments related to the net share settlement of restricted stock units, and proceeds from the exercise of options to acquire common stock. Net cash used by financing activities in the first six months of fiscal 2024 was $51.7 million compared to $139.4 million in the first six months of fiscal 2023. This $87.7 million decrease was due to the following activities. During the first six months of fiscal 2024, we had no balance outstanding on our long-term debt, while during the first six months of fiscal 2023 we made discretionary payments totaling $85.0 million on revolving loans under the 2022 Credit Agreement. During the first six months of fiscal 2024, we repurchased approximately 0.4 million shares of common stock for $30.0 million compared to repurchases in the first six months of fiscal 2023 of approximately 0.2 million shares of common stock for $20.0 million. Payments for tax withholdings on vesting of RSUs partially offset by employee exercises of stock options used net cash flows of $21.7 million in the first six months of fiscal 2024, a decrease of approximately $12.7 million from the net $34.4 million used in the first six months of fiscal 2023.

Accounts receivable, net

(In thousands) |  | June 29, 2024 |  |  | December 30, 2023 |  |  | $ Change |  |  | % Change |
Accounts receivable, net |  | $ | 103,442 |  |  | $ | 104,373 |  |  | $ | (931 | ) |  |  | (0.9 | )%
Days sales outstanding |  |  | 76 |  |  |  | 56 |  |  |  | 20 |  |  |  |  |

Accounts receivable, net as of June 29, 2024 decreased by approximately $0.9 million, or 1%, compared to December 30, 2023. This decrease was due to lower revenue shipments as well as the timing of when our customers want our products. We calculate Days sales outstanding on the basis of a 365-day year as Accounts receivable, net at the end of the quarter divided by sales during the quarter annualized and then multiplied by 365.

Inventories

(In thousands) |  | June 29, 2024 |  |  | December 30, 2023 |  |  | $ Change |  |  | % Change |
Inventories |  | $ | 101,556 |  |  | $ | 98,826 |  |  | $ | 2,730 |  |  |  | 2.8 | %
Days of inventory on hand |  |  | 236 |  |  |  | 175 |  |  |  | 61 |  |  |  |  |

Inventories as of June 29, 2024 increased $2.7 million, or approximately 3%, compared to December 30, 2023 primarily as a result of new product ramps. Days of inventory on hand increased over the period due to lower revenue.

The Days of inventory on hand ratio compares the inventory balance at the end of a quarter to the cost of sales in that quarter. We calculate Days of inventory on hand on the basis of a 365-day year as Inventories at the end of the quarter divided by Cost of sales during the quarter annualized and then multiplied by 365.

Credit Arrangements

On September 1, 2022, we entered into our 2022 Credit Agreement. The details of this arrangement are described in "Note 5 - Long-Term Debt" in the Notes to Consolidated Financial Statements of this Quarterly Report on Form 10-Q.

As of June 29, 2024, we had no used or unused credit arrangements beyond the secured revolving loan facility described in the 2022 Credit Agreement.

Share Repurchase Program

See Part II, Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds,” of this Quarterly Report on Form 10-Q for more information about the share repurchase program.

- 24 -

Table of Contents

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk represents the risk of loss that may impact our financial position due to adverse changes in financial market prices and rates. Our market risk exposure is primarily a result of fluctuations in foreign currency exchange rates and interest rates. We assess these risks on a regular basis and have established policies that are designed to protect against the adverse effects of these and other potential exposures. There have been no material changes to either the foreign currency exchange rate risk or interest rate risk previously disclosed in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk," of our 2023 10-K.

ITEM 4. CONTROLS AND PROCEDURES

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

In connection with the filing of this Quarterly Report on Form 10-Q, our management, including our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting

There were no changes in our internal controls over financial reporting (as defined in Rules 13a-15(f) under the Exchange Act) that occurred during the second quarter of fiscal 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Inherent Limitations on Effectiveness of Controls

We do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent all errors and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of a simple error or mistake. Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management override of the controls. The design of any system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions; over time, controls may become inadequate because of changes in conditions, or the degree of compliance with policies or procedures may deteriorate. Because of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.

- 25 -

Table of Contents

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

The information set forth above under "Note 12 - Contingencies - Legal Proceedings" contained in the Notes to Consolidated Financial Statements is incorporated herein by reference.

ITEM 1A. RISK FACTORS

In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors associated with our business previously described in Part I, Item 1A, “Risk Factors,” in our 2023 10-K. There have been no material changes in the risk factors included in our 2023 10-K, and this report should be read in conjunction with the risk factors set forth in our 2023 10-K. These risk factors are not the only risks facing our company. Additional risks and uncertainties not presently known to us or that we may currently deem to be immaterial could materially adversely affect our business, financial condition, or operating results, including those related to adverse macroeconomic conditions, such as rising inflation and labor shortages, which may affect demand for our products or increase our product or labor costs, negatively impacting our revenues, gross margins, and overall financial results. If any of these risks occur, our business, financial condition, operating results, and cash flows could be materially adversely affected, and the trading price of our common stock could decline. These factors, together with all of the other information in this Quarterly Report on Form 10-Q, including our unaudited condensed consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q, should be carefully considered before making an investment decision relating to our common stock.

- 26 -

Table of Contents

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Issuer Purchases of Equity Securities

On November 30, 2023, we announced that our Board of Directors had approved a stock repurchase program pursuant to which up to $250 million of outstanding common stock could be repurchased from time to time (the "2024 Repurchase Program"). The duration of the 2024 Repurchase Program is through December 28, 2024. During the second quarter of fiscal 2024, we repurchased 143,402 shares for $10.0 million, or an average price paid per share of $69.73. All repurchases were open market transactions funded from available working capital. All shares repurchased pursuant to the 2024 Repurchase Program were retired by the end of the second quarter of fiscal 2024.

The following table contains information regarding our repurchases of our common stock that is registered pursuant to Section 12 of the Securities Exchange Act of 1934 during the second quarter of fiscal 2024.

Period |  | Total Number of Shares Purchased |  |  | Average Price Paid per Share |  |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a) |  |  | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs ($M) (b) |
March 31, 2024 through April 27, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | 230.0 |
April 28, 2024 through May 25, 2024 |  |  | 143,402 |  |  | $ | 69.73 |  |  |  | 143,402 |  |  | $ | 220.0 |
May 26, 2024 through June 29, 2024 |  |  | — |  |  | $ | — |  |  |  | — |  |  | $ | 220.0 |
Total |  |  | 143,402 |  |  | $ | 69.73 |  |  |  | 143,402 |  |  | $ | 220.0 |

(a) |  | All repurchases during the quarter were open-market transactions funded from available working capital made under the authorization from our Board of Directors to purchase up to $250.0 million of our common stock announced November 30, 2023.
(b) |  | As of June 29, 2024, this amount consisted of the remaining portion of the $250.0 million program authorized through December 28, 2024 that was announced November 30, 2023.

ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Plans

On May 10, 2024, Esam Elashmawi, Interim Chief Executive Officer and Chief Marketing and Strategy Officer, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense condition of Rule 10b5-1(c), pursuant to which an estimated aggregate of 47,000 shares of our Common Stock may be sold. The aggregate number of shares sold may differ based on tax withholdings for vesting stock awards, actual market achievement for performance RSUs, and actual number of future shares purchased under the Employee Stock Purchase Plan. The duration of the trading arrangement is until May 9, 2025, or earlier if all transactions under the trading arrangement are completed.

- 27 -

Table of Contents

ITEM 6. EXHIBITS

Exhibit Number |  | Description
31.1 |  | Certification of Chief Executive Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 |  | Certification of Chief Financial Officer pursuant to the Securities Exchange Act of 1934 Rule 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 |  | Certification of Chief Executive Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification of Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | Inline XBRL Instance Document (the Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.SCH |  | Inline XBRL Taxonomy Extension Schema Document
101.CAL |  | Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF |  | Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB |  | Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE |  | Inline XBRL Taxonomy Extension Presentation Linkbase Document
104 |  | Cover Page Interactive Data File - formatted in Inline XBRL and included in Exhibit 101

- 28 -

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| LATTICE SEMICONDUCTOR CORPORATION
| (Registrant)
| /s/ Sherri Luther
| Sherri Luther
| Chief Financial Officer
| (Principal Financial and Accounting Officer)

Date: July 30, 2024

- 29 -